Tackling challenges to end tuberculosis

Next week, world leaders will meet to take part in the first UN High Level Meeting on TB, in history. As QuantuMDx is the only UK company accredited to attend

Share
QuantuMDx announces executive appointments

  QuantuMDx Group Ltd today announced two key leadership appointments. Dr Allan Brown has been appointed Chief Operating Officer and David Matthews joins as Chief Financial Officer. “These appointments represent the

Share
The Consul General of India visits QuantuMDx

The Consul General of India, Dr Aman Puri, visited Newcastle upon Tyne yesterday which included a tour of laboratories at QuantuMDx Group Limited (QuantuMDx). As a life science tools and diagnostics company, QuantuMDx

Share
QuantuMDx achieves ISO 13485: 2016 certification

QuantuMDx Group has been awarded ISO 13485: 2016 certification – representing the highest standard of quality a medical devices company can achieve. ISO 13485 is a quality system standard designed

Share
QuantuMDx raises $12m and strengthens Board as company eyes commercialisation of Q-POC™ portable MDx platform

Newcastle upon Tyne, UK – 23 January 2018 Life science tools and diagnostics company QuantuMDx announced today it has closed a $12m funding round. As part of this round it

Share
Press Release: On World Cancer Day, Global Good and QuantuMDx Partner to Combat Cervical Cancer

2 February 2017, Newcastle upon Tyne, UK QuantuMDx Group announce an assay co-development and commercialisation agreement with The Global Good Fund, managed by Intellectual Ventures, to develop a rapid, low-cost

Share
Press Release: QuantuMDx CEO Elaine Warburton OBE appointed to Precision Medicine Catapult Board of Directors

15 December 2016, Newcastle upon Tyne QuantuMDx today announced the appointment of CEO Elaine Warburton OBE to the Precision Medicine Catapult Board of Directors as Non Executive Director. Recognised with

Share
Press Release: QuantuMDx receives grant funding for TB diagnostic

28th November 2016, Newcastle upon Tyne, UK QuantuMDx announced today that it received funding from the Bill & Melinda Gates Foundation to further develop and test its CAPTURE-XT™ pathogen concentration

Share
Press Release: QuantuMDx CEO Elaine Warburton OBE to join Prime Minister on her first major overseas trade visit to India

07 November 2016, Newcastle upon Tyne QuantuMDx CEO Elaine Warburton OBE has been invited by Prime Minister Theresa May to join a small group of delegates representing the best of

Share